CatsWannaBeCats.Com | Oh Rahbek | Activity https://www.catswannabecats.com/members/kisssunday41/activity/ Activity feed for Oh Rahbek. Wed, 24 Jun 2026 15:14:21 -0400 https://buddypress.org/?v=7.2.0 en-CA 30 hourly 2 28c4df6bae3b8ec6ba9d88d00fb0e6a3 Oh Rahbek posted an update: Local IR (20 Gy) to nude mice bearing HEp-2 tumors […] https://www.catswannabecats.com/activity/p/25317/ Sun, 08 Jun 2025 20:18:31 -0400 Local IR (20 Gy) to nude mice bearing HEp-2 tumors significantly reduced tumor burden, while fewer effects on tumor burden in mice carrying CXCL10-KO tumors were observed. We furtherly evaluated the possible roles the chemokine receptor CXCR3 plays in mediating the sensitivity of cultured HEp-2 cells to IR. Altered expression of CXCR3 in HEp-2…[Read more]

]]> 0 77a83ee006c5f9272b88fb294692e096 Oh Rahbek posted an update: One in five patients experience chronic pain 12months […] https://www.catswannabecats.com/activity/p/14829/ Mon, 02 Jun 2025 09:13:11 -0400 One in five patients experience chronic pain 12months following total knee arthroplasty (TKA). This longitudinal study used a person-centred approach to identify subgroups of patients with distinct chronic pain profiles following TKA and identified preoperative characteristics associated with these profiles.

On the day before surgery, 202…[Read more]

]]> 0 f5a4cada25afcf9ca761fea116a2f4a1 Oh Rahbek posted an update: Barriers highlighted included governance, financial, human […] https://www.catswannabecats.com/activity/p/7735/ Sat, 31 May 2025 19:52:33 -0400 Barriers highlighted included governance, financial, human resource, information and infrastructure challenges. In 2019, majority of respondents indicated inadequate guidelines dissemination, lack of financial resources, inadequate personnel, lack of equipped laboratories and lack of instructional materials among major barriers.

support…[Read more]

]]> 0 9d39b6a614e4e249530ba49e3f67e10f Oh Rahbek became a registered member https://www.catswannabecats.com/activity/p/7552/ Sat, 31 May 2025 19:32:14 -0400 0